Cytokine concentration in eye of patients with age-related macular degeneration before and after anti-VEGF therapy

Cytokine concentration in aqueous humor of patients with neovascular age-related macular degeneration before and after anti-VEGF therapy - Cytokine concentration in eyes with age-related macular degeneration

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043667

Enrollment

Registered

2021-03-18

Start date

2021-03-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neovascular age-related macular degeneration

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient with neovascular age-related macular degeneration, male or female, 50 years old or older with informed consent.

Exclusion criteria

Exclusion criteria: Patients are judged to be inappropriate by doctors in charge. Especially the patients with narrow angle who are concerned to occur capsule rupture of lens are excluded. Patients who would like to withdraw their consent.

Design outcomes

Primary

Measure	Time frame
The cytokines concentration in aqueous humor before and after the intravitreal injection of anti-vascular endothelial growth factor	—

Countries

Japan

Contacts

Public ContactTomoko Sawada

Shiga University of Medical Science Department of Ophthalmology

tsawada@belle.shiga-med.ac.jp0775482276

Outcome results